Showing results (901-910 of 8,120) with videos related to

Sort By:
Pageof 812
Haematologica|December 3, 2011
Tyrosine phosphorylation of WASP promotes calpain-mediated podosome disassemblyLee Macpherson, James Monypenny, Michael P Blundell, et al.
Haematologica|December 3, 2011
Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literatureDavid J Araten, Rosario Notaro, Howard T Thaler, et al.
Haematologica|December 3, 2011
A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technologyJulien Thibaut, Yves Mérieux, Dominique Rigal, et al.
Haematologica|June 13, 2012
Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myelomaJens Hillengass, Sofia Ayyaz, Kerstin Kilk, et al.
Haematologica|June 13, 2012
Metalloreductase Steap3 coordinates the regulation of iron homeostasis and inflammatory responsesFan Zhang, Yunlong Tao, Zhuzhen Zhang, et al.
Haematologica|June 13, 2012
High frequency of ribosomal protein gene deletions in Italian Diamond-Blackfan anemia patients detected by multiplex ligation-dependent probe amplification assayPaola Quarello, Emanuela Garelli, Alfredo Brusco, et al.
Haematologica|June 13, 2012
Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designationKohei Hosokawa, Takamasa Katagiri, Naomi Sugimori, et al.
Haematologica|August 13, 2013
Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemiaKiriko Kaneko, Kazumichi Furuyama, Tohru Fujiwara, et al.
Haematologica|August 13, 2013
Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesisTimothy J Satchwell, Stephanie Pellegrin, Paola Bianchi, et al.
Haematologica|August 13, 2013
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab eraTamar Tadmor, Alessia Bari, Stefano Sacchi, et al.
Pageof 812